Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase 3, Randomized, Placebo-controlled, Multicenter, Double-blind Study to Evaluate the Safety and Efficacy of Telotristat Etiprate (LX1606) in Patients with Carcinoid Syndrome Estudio en fase 3, aleatorizado, multicéntrico, doble ciego y controlado con placebo para evaluar la seguridad y la eficacia de etiprato de telotristat (LX1606) en pacientes con síndrome carcinoide https://www.kusajili.fr:443/Trial/bZnpuMOjb0qO5y1p0gwLNg%24a-phase-3-randomized-placebo-controlled-multicenter-double-blind-study-to-evaluate-the-safety-and-efficacy-of-telotristat-etipr
I have read and accept the terms of use of the site and the Privacy Policy
Send your message